{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T13:09:14Z","timestamp":1785416954021,"version":"3.56.0"},"reference-count":118,"publisher":"Wiley","issue":"s3","license":[{"start":{"date-parts":[[2006,8,2]],"date-time":"2006-08-02T00:00:00Z","timestamp":1154476800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Investigation"],"published-print":{"date-parts":[[2006,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Endothelin (ET)\u20101 is a potent vasoconstrictor peptide with pro\u2010inflammatory, mitogenic, and pro\u2010fibrotic properties that is closely involved in both normal renal physiology and pathology. ET\u20101 exerts a wide variety of biological effects, including constriction of cortical and medullary vessels, mesangial cell contraction, stimulation of extracellular matrix production, and inhibition of sodium and water reabsorption along the collecting duct, effects that are primarily mediated in an autocrine\/paracrine manner. Increasing evidence indicates that the ET system is involved in an array of renal disorders. These comprise chronic proteinuric states associated with progressive glomerular and tubulointerstitial fibrosis, including diabetic and hypertensive nephropathy, glomerulonephritis and others. In addition, ET\u20101 is causally linked to renal disorders characterized by increased renal vascular resistance, including acute ischaemic renal failure, calcineurin inhibitor toxicity, endotoxaemia, hepatorenal syndrome and others. Furthermore, derangement of the ET system may be involved in conditions associated with inappropriate sodium and water retention; for example, in congestive heart failure and hepatic cirrhosis. Both selective and non\u2010selective ET receptor antagonist have been developed and tested in animal models with promising results. As key events in progressive renal injury like inflammation and fibrosis are mediated via both ET<jats:sub>A<\/jats:sub> and ET<jats:sub>B<\/jats:sub> receptors, while constrictor effects are primarily transduced by ET<jats:sub>A<\/jats:sub> receptors, dual ET receptor blockade may be superior over selective ET<jats:sub>A<\/jats:sub> antagonism. Several compounds have been developed with remarkable effects in several models of acute and progressive renal injury. Thus, clinical studies are required to assess whether these results can be confirmed in humans, hopefully leading to novel and effective therapeutic options with few side effects.<\/jats:p>","DOI":"10.1111\/j.1365-2362.2006.01689.x","type":"journal-article","created":{"date-parts":[[2006,8,2]],"date-time":"2006-08-02T23:14:53Z","timestamp":1154560493000},"page":"78-88","source":"Crossref","is-referenced-by-count":96,"title":["Role of endothelin and endothelin receptor antagonists in renal disease"],"prefix":"10.1111","volume":"36","author":[{"given":"W.","family":"Neuhofer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Pittrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,8,2]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/332411a0"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.41.1.851"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1165\/ajrcmb.11.4.7917311"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2001.01256.x"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1080\/07853890410018925"},{"key":"e_1_2_6_7_2","first-page":"F411","article-title":"Systemic and renal effect of intravenous infusion of endothelin\u20101 in healthy human volunteers","volume":"266","author":"Sorensen SS","year":"1994","journal-title":"Am J Physiol"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.37.4.1171"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.36.2.282"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00540.2002"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-001-0284-4"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119297"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1993.53"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1991.172"},{"key":"e_1_2_6_15_2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1681\/ASN.V3158","article-title":"Radiocontrast agents induce endothelin release in vivo and in vitro","volume":"3","author":"Heyman SN","year":"1992","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(97)90004-4"},{"key":"e_1_2_6_17_2","first-page":"F449","article-title":"Endothelin receptor mRNA expression in renal medulla identified by in situ RT\u2010PCR","volume":"269","author":"Chow LH","year":"1995","journal-title":"Am J Physiol"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115822"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199816121-00008"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(02)02228-8"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200110000-00013"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI8609"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200421064"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117976"},{"key":"e_1_2_6_25_2","first-page":"1028","article-title":"Endothelin inhibits vasopressin action in rat inner medullary collecting duct via the ETB receptor","volume":"267","author":"Edwards RM","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00041552-200007000-00016"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118567"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198209093071104"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V971213"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199811123392007"},{"key":"e_1_2_6_31_2","first-page":"S29","article-title":"Role of increased glomerular protein traffic in the progression of renal failure","volume":"62","author":"Bruzzi I","year":"1997","journal-title":"Kidney Int Suppl"},{"key":"e_1_2_6_32_2","first-page":"461","article-title":"The renal toxicity of sustained glomerular protein traffic","volume":"73","author":"Benigni A","year":"1995","journal-title":"Lab Invest"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/15.suppl_6.50"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0272-6386(95)90058-6"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2000.00023.x"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1991.38"},{"key":"e_1_2_6_37_2","first-page":"1241","article-title":"Time course and localization of endothelin\u20101 gene expression in a model of renal disease progression","volume":"151","author":"Bruzzi I","year":"1997","journal-title":"Am J Pathol"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2000.00420.x"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-200102000-00009"},{"key":"e_1_2_6_40_2","first-page":"16","article-title":"Constitutive expression of endothelin gene in cultured human mesangial cells and its modulation by transforming growth factor\u2010beta, thrombin, and a thromboxane A2 analogue","volume":"64","author":"Zoja C","year":"1991","journal-title":"Lab Invest"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.137.11.5000"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2613.2000.00173.x"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.96.5.1593"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1992.361"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.100.18.1901"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1711620207"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI2132"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.37.2.490"},{"key":"e_1_2_6_49_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.18.1.87"},{"key":"e_1_2_6_50_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000032260.01569.64"},{"key":"e_1_2_6_51_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.47.3.450"},{"key":"e_1_2_6_52_2","doi-asserted-by":"publisher","DOI":"10.1159\/000046319"},{"key":"e_1_2_6_53_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-200312000-00009"},{"key":"e_1_2_6_54_2","doi-asserted-by":"publisher","DOI":"10.2337\/diab.44.8.895"},{"key":"e_1_2_6_55_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00019.2003"},{"key":"e_1_2_6_56_2","doi-asserted-by":"publisher","DOI":"10.1159\/000020519"},{"key":"e_1_2_6_57_2","first-page":"233","article-title":"Renal expression of mRNAs for endothelin\u20101, endothelin\u20103 and endothelin receptors in NZB\/W F1 mice","volume":"16","author":"Nakamura T","year":"1993","journal-title":"Ren Physiol Biochem"},{"key":"e_1_2_6_58_2","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1681\/ASN.V581585","article-title":"Modulation of glomerular endothelin and endothelin receptor gene expression in aminonucleoside\u2010induced nephrosis","volume":"5","author":"Nakamura T","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_6_59_2","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1681\/ASN.V12112321","article-title":"Renal endothelin\u20101 and endothelin receptor type B expression in glomerular diseases with proteinuria","volume":"12","author":"Lehrke I","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_6_60_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1996.397"},{"key":"e_1_2_6_61_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1998.00011.x"},{"key":"e_1_2_6_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(98)00058-8"},{"key":"e_1_2_6_63_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199605303342207"},{"key":"e_1_2_6_64_2","unstructured":"NeuhoferW BeckF.Cell survival in the hostile renal medulla.Annu Rev Physiol2005."},{"key":"e_1_2_6_65_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199503093321006"},{"key":"e_1_2_6_66_2","doi-asserted-by":"publisher","DOI":"10.1097\/00041552-199707000-00015"},{"key":"e_1_2_6_67_2","doi-asserted-by":"publisher","DOI":"10.1159\/000078874"},{"key":"e_1_2_6_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(99)00042-4"},{"key":"e_1_2_6_69_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1996.1886"},{"key":"e_1_2_6_70_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.2001.5485"},{"key":"e_1_2_6_71_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfg521"},{"key":"e_1_2_6_72_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200101270-00007"},{"key":"e_1_2_6_73_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199908000-00004"},{"key":"e_1_2_6_74_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199807000-00013"},{"key":"e_1_2_6_75_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-200104000-00015"},{"key":"e_1_2_6_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(92)90774-X"},{"key":"e_1_2_6_77_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/17.9.1578"},{"key":"e_1_2_6_78_2","first-page":"F135","article-title":"Effect of an endothelin\u2010receptor antagonist on ischemic acute renal failure","volume":"266","author":"Chan L","year":"1994","journal-title":"Am J Physiol"},{"key":"e_1_2_6_79_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00050.2001"},{"key":"e_1_2_6_80_2","first-page":"S136","article-title":"Immune and nonimmune mechanisms of chronic rejection of kidney allografts","volume":"14","author":"Azuma H","year":"1995","journal-title":"J Heart Lung Transplant"},{"key":"e_1_2_6_81_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V123589"},{"key":"e_1_2_6_82_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000063127.02261.E4"},{"key":"e_1_2_6_83_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200207270-00004"},{"key":"e_1_2_6_84_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(99)00371-1"},{"key":"e_1_2_6_85_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/14.4.872"},{"key":"e_1_2_6_86_2","first-page":"S27","article-title":"Cellular mechanisms of cyclosporine A\u2010associated side effects: role of endothelin","volume":"61","author":"Meyer\u2010Lehnert H","year":"1997","journal-title":"Kidney Int Suppl"},{"key":"e_1_2_6_87_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115293"},{"key":"e_1_2_6_88_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2000.00838.x"},{"key":"e_1_2_6_89_2","first-page":"153","article-title":"Enhanced expression of endothelin\u2010A receptor in human transplant renal arteriosclerosis","volume":"11","author":"Nakatani T","year":"2003","journal-title":"Int J Mol Med"},{"key":"e_1_2_6_90_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(97)00562-9"},{"key":"e_1_2_6_91_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.024703"},{"key":"e_1_2_6_92_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.50.1.111"},{"key":"e_1_2_6_93_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(97)80317-0"},{"key":"e_1_2_6_94_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.2000.tb01010.x"},{"key":"e_1_2_6_95_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1386-6346(02)00082-7"},{"key":"e_1_2_6_96_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(97)01173-1"},{"key":"e_1_2_6_97_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199507150-00017"},{"key":"e_1_2_6_98_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1993.263"},{"key":"e_1_2_6_99_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(96)90366-2"},{"key":"e_1_2_6_100_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.ndt.a027320"},{"key":"e_1_2_6_101_2","doi-asserted-by":"publisher","DOI":"10.1159\/000045906"},{"key":"e_1_2_6_102_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)64005-0"},{"key":"e_1_2_6_103_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1995.61"},{"key":"e_1_2_6_104_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/12.5.1001"},{"key":"e_1_2_6_105_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.99.16.2185"},{"key":"e_1_2_6_106_2","doi-asserted-by":"publisher","DOI":"10.1159\/000080052"},{"key":"e_1_2_6_107_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.24.2.183"},{"key":"e_1_2_6_108_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.1998.275.1.R245"},{"key":"e_1_2_6_109_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.2000.278.2.F279"},{"key":"e_1_2_6_110_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(96)00212-8"},{"key":"e_1_2_6_111_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.31.4.995"},{"key":"e_1_2_6_112_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.33.1.137"},{"key":"e_1_2_6_113_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.31.1.397"},{"key":"e_1_2_6_114_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.28.3.379"},{"key":"e_1_2_6_115_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200018120-00015"},{"key":"e_1_2_6_116_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(01)00558-2"},{"key":"e_1_2_6_117_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000109139.69775.EB"},{"key":"e_1_2_6_118_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000042165.63601.65"},{"key":"e_1_2_6_119_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(02)00658-2"}],"container-title":["European Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2362.2006.01689.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2362.2006.01689.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T08:57:44Z","timestamp":1695805064000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2362.2006.01689.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8,2]]},"references-count":118,"journal-issue":{"issue":"s3","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["10.1111\/j.1365-2362.2006.01689.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2362.2006.01689.x","archive":["Portico"],"relation":{},"ISSN":["0014-2972","1365-2362"],"issn-type":[{"value":"0014-2972","type":"print"},{"value":"1365-2362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8,2]]}}}